Boston IVF Announces Addition of Reproductive Endocrinologist Erica Bove, MD to its Syracuse, NY Fertility Center Team

Fertility doctor in Syracuse

Erica Bove, MD

Dr. Bove will provide Syracuse patients with a full range of in-house treatment options for infertility and family-building.

I am thrilled to now deliver this same level of evidence-based care for patients in Syracuse. There is no greater honor than to see my patients fulfill their dream of becoming a parent.”

— Erica Bove, MD

SYRACUSE, NEW YORK, USA, July 8, 2020 /EINPresswire.com/ — Boston IVF, one of the nation’s top fertility networks, with more than 90,000 babies born since 1986, today announced the newest addition of its Syracuse, NY fertility team, Erica Bove (Mahany), MD.

Dr. Bove arrives in Syracuse from Boston IVF’s center in Albany – where she maximized patient success via the fertility network’s renowned laboratory technologies and award-winning scientific team. Board-certified in both obstetrics/gynecology and reproductive endocrinology/infertility – she becomes the chief reproductive endocrinologist at Boston IVF’s full-service fertility center and IVF laboratory on Widewaters Parkway in Syracuse.

The addition of Dr. Bove is encouraging news for individuals and couples in Syracuse who wish to receive an advanced level of care in their journey to parenthood via assisted reproductive technologies. She provides a full range of state-of-the-art, in-house diagnostic and treatment options for female and male infertility, elective egg freezing, LGBTQ family building, and fertility preservation prior to cancer treatment.

"Boston IVF is thrilled that patients in Syracuse now have access to a physician with the caliber of experience and training as Dr. Bove," remarked David Stern, Chief Executive Officer at Boston IVF.

“Our fertility center in Syracuse serves a region that has been under-served in the area of reproductive medicine and personalized treatments for all patients. Boston IVF’s model of care minimizes time in treatment, reduces costs, and maximizes the chance for a healthy baby,” added Stern.

"While in practice at Boston IVF’s fertility center in Albany, I saw firsthand the real difference a dynamic, national network like ours can make to enhance positive outcomes for our patients at the local level. Because we treat each patient uniquely – and because each individual has their own specific set of circumstances – having access to Boston IVF’s national resources, technologies, clinical trials and innovative testing has given my patients a comprehensive, tailored treatment experience they can’t find anywhere else. I am thrilled to now deliver this same level of patient-centered, evidence-based care for patients in Syracuse. There is no greater honor than to see my patients fulfill their dream of becoming a parent," added Bove.

Prior to joining Boston IVF – Dr. Bove excelled as a reproductive endocrinologist at the University of Michigan’s IVF program, where she treated patients and conducted nationally-recognized research focusing on OB/GYN education and the intersection of metabolism and reproduction. She received her medical degree from the University of Vermont College of Medicine, completed her OB/GYN residency at New York Presbyterian Hospital/Columbia University, and her subspecialty fellowship in reproductive endocrinology at the University of Michigan, where she was faculty for several years before joining Boston IVF.

ABOUT BOSTON IVF
One of the nation’s most experienced fertility networks, with over 90,000 babies born since 1986, Boston IVF has earned a reputation for innovative care, research, and next-generation fertility treatment options. With numerous "firsts" in the field of reproductive care and over 25 centers throughout New England, New York, and Indiana, Boston IVF utilizes cutting-edge reproductive science and customized care to maximize patient outcomes. For more information, please visit www.bostonivf.com

Theo LoPreste
Boston IVF
+1 781-850-5367
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Seattle's AVM Biotechnology Expands Executive Team in Preparation for Oncology and COVID-19 Clinical Trials

AVM Biotechnology

SEATTLE, WA, USA, July 8, 2020 /EINPresswire.com/ — Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is applying to begin trials treating moderate-severely ill COVID-19 patients, announced today the hiring of Janet R. Rea, MSPH, as Chief Operating Officer. As COO, Rea will lead operations and direct regulatory affairs as the company conducts clinical trials and brings AVM0703 to market.

“I am delighted that Janet Rea will join our team at AVM Biotechnology as the Chief Operating Officer. Having worked with Janet during a pivotal time at Protein Sciences while pursuing Flublok® FDA approval,” said Dr. Manon Cox, AVM Biotechnology’s Executive Board Member, “I know that her passion for quality and her tremendous experience in the transition from development into commercialization is exactly what we need at this crucial time at AVM now that our lead product is moving into the clinic.”

Janet R. Rea, MSPH, RAC, brings over 35 years of industry leadership experience in clinical development through commercialization in biologics and small molecules, with focus on oncology, infectious diseases, orphan and rare diseases. She obtained her B.S. in microbiology and M.S. in Public Health from the University of Washington. Her career in the healthcare industry began with then-American Hospital Supply Corporation (now Baxter), followed by Genetic Systems. Ms. Rea was an early employee of Seattle-based Immunex Corporation, where she played a key role in the company’s first licensed product, Leukine®. She held positions with increasing levels of responsibility with MDS Pharma and Targeted Genetics, as well as executive positions with AVI BioPharma (now Sarepta), Poniard Pharmaceuticals and Protein Sciences Corporation (acquired by Sanofi), and Therapeutic Proteins International. Most recently, she was SVP of Regulatory, Quality and Clinical Affairs at Atossa Therapeutics (Genetics) with focus on breast cancer and COVID-19 therapy development. She has also operated a consulting practice to both small and large organizations and has lectured at the University of Washington for the Biomedical Regulatory Affairs Certificate and Master’s Program, where she also served as a part time Assistant Clinical Professor for two years. Ms. Rea will serve as a non-voting member of AVM’s Board of Directors.

"I am thrilled and honored to be joining AVM Biotechnology and look forward to working with this distinguished team to make new therapies available.” Ms. Rea said. Named one of the “10 Best Biotech & Pharma Companies to Keep an Eye On in 2019” by Mirror Review, AVM Biotechnology was founded in 2008 by Dr. Theresa Deisher, Ph.D. With over 30 years of successful pharmaceutical research experience and holding over 47 patents, Dr. Deisher leads a team of scientists dedicated to changing the meaning of a diagnosis of cancer, autoimmunity, or chronic infectious disease for patients and their loved ones. In April 2020, AVM received FDA permission to begin clinical trials to test its lead molecule AVM0703 for treatment of relapsed/refractory lymphoid malignancies, and is filing for FDA approval to begin clinical trials in treating COVID-19 and influenza induced ARDS. AVM’s passion is to deliver drugs that work rapidly and that are safe, effective, and affordable to treat serious worldwide illnesses such as cancer, autoimmunity, and life-altering infectious disease. AVM develops products that improve outcomes without additional suffering because side effects from treatments of cancers or infections should never be worse than the diseases themselves. The addition of Janet Rea to the AVM team, which includes a global group of experienced biotech advisors, makes AVM well positioned to bring AVM0703 to market in treating multiple conditions.

Contact Jena Dalpez Jdalpez@AVMBiotech.com

ALL INFORMATION CONTAINED HEREIN HAS BEEN PROVIDED BY THE COMPANY AND NO OTHER PARTY HAS INDEPENDENTLY VERIFIED ANY OF THE INFORMATION, INCLUDING THE FINANCIAL ESTIMATES AND PROJECTIONS CONTAINED HEREIN. SOME OF THE STATEMENTS IN THE MEMORANDUM ARE “FORWARD-LOOKING STATEMENTS.” THESE FORWARD-LOOKING STATEMENTS INCLUDE, BUT ARE NOT LIMITED TO, STATEMENTS ABOUT THE COMPANY’S PLANS, OBJECTIVES, EXPECTATIONS AND INTENTIONS AND OTHER STATEMENTS CONTAINED IN THE MEMORANDUM THAT ARE NOT HISTORICAL FACTS. WHEN USED IN THIS MEMORANDUM, THE WORDS “ASSUMES,” “ANTICIPATES,” “BELIEVES,” “CONTINUE,” “COULD,” “EXPECTS,” “FORECASTS,” “INTENDS,” “MAY,” “PLANS,” “SEEKS,” “SHOULD,” OR “WILL” OR THE NEGATIVE OF THESE TERMS OR SIMILAR EXPRESSIONS ARE GENERALLY INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. BECAUSE THESE FORWARD-LOOKING STATEMENTS INVOLVE RISKS AND UNCERTAINTIES, THERE ARE IMPORTANT FACTORS THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED OR IMPLIED BY THESE FORWARD-LOOKING STATEMENTS, INCLUDING THE COMPANY’S PLANS, OBJECTIVES, EXPECTATIONS AND INTENTIONS AND OTHER FACTORS DISCUSSED UNDER “RISK FACTORS” SUCH STATEMENTS, ESTIMATES AND PROJECTIONS REFLECT VARIOUS ASSUMPTIONS OF THE COMPANY THAT MAY OR MAY NOT PROVE TO BE CORRECT. AND NO REPRESENTATION IS MADE AND NO ASSURANCE CAN BE GIVEN THAT THE COMPANY CAN OR WILL ATTAIN SUCH RESULTS.

Jena Dalpez
AVM Biotechnology
email us here
+1 206-906-9922
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Welche Antivirus-Software schützt Sie am besten? AV-Comparatives präsentiert die besten Antivirus-Software für H1 2020

Spotlight on Security

Spotlight on Security

Logo AV-Comparatives

Logo AV-Comparatives

Real-World Protection Test H1 2020 - by AV-Comparatives

Real-World Protection Test H1 2020 – by AV-Comparatives

Malware Protection Test March 2020 - by AV-Comparatives

Malware Protection Test March 2020 – by AV-Comparatives

Speed Impact Test April 2020 - by AV-Comparatives

Speed Impact Test April 2020 – by AV-Comparatives

AV-Comparatives hat in einem Langzeittest dieses Jahres die leistungsfähigsten Antiviren-Produkte für Verbraucher auf Herz- Und Nieren getestet.

Ransomware, Phishing, Malware, Zero-Days. Cyberkriminelle benutzen verschiedene Bedrohungen, um Ihren Computer anzugreifen. Wir empfehlen dringend eine Antivirus-Software zum Schutz Ihres Gerätes.”

— Peter Stelzhammer, co-founder, AV-Comparatives

INNSBRUCK, TIROL, ÖSTERREICH, July 8, 2020 /EINPresswire.com/ — AV-Comparatives hat in einem Langzeittest in den ersten sechs Monaten dieses Jahres die leistungsfähigsten Sicherheitsprodukte für Heimanwender angekündigt. 17 beliebte Antivirenprogramme wurden einer Reihe vonTests unterzogen, um festzustellen, wie wirksam sie sich gegen Bedrohungen schützen und welche Auswirkungen sie auf die Systemleistung haben. Für jeden Test wurden 3 Kategorien vergeben: Advanced+, Advanced und Standard.

Insgesamt bietet die Testserie eine eingehende Analyse der Schutzwirkung und der Handhabung der getesteten Programme. Die detailierten Testberichte für die drei Tests können kostenlos auf der Website von AV-Comparatives heruntergeladen werden.

https://www.av-comparatives.org/tests/real-world-protection-test-february-may-2020/

https://www.av-comparatives.org/tests/malware-protection-test-march-2020/

https://www.av-comparatives.org/tests/performance-test-april-2020/

Geprüfte Produkte:

Avast Free Antivirus, AVG Free Antivirus, Avira Antivirus Pro, Bitdefender Internet Security, ESET Internet Security, F-Secure SAFE, G DATA Internet Security, K7 Total Security, Kaspersky Internet Security, Mcafee Total Protection, Microsoft Windows Defender, Nortonlifelock Norton 360 Deluxe, Panda Free Antivirus, Total AV Antivirus Pro, Total Defense Essential Antivirus, Trend Micro Internet Security, VIPRE Advanced Security 

Die drei Tests in der Serie waren wie folgt. Der Real-World Protection Test simuliert die Handlungen eines typischen Benutzers, der versehentlich online auf Malware trifft. Der Test erlaubt die Verwendung aller Schutzkomponenten der geprüften Programme, z.B. URL-Blocker, Reputationsdienste, Heuristik, lokale und cloud-basierte Signaturen und Verhaltenserkennung. Die Besonderheit ist, dass alle Threats ausgeführt werden. Für jede Malware-Probe wird einem geprüften Produkt ein Punkt gutgeschrieben, wenn es zu einem bestimmten Zeitpunkt verhindert, dass das System infiziert wird.

Der Malware Protection Test berücksichtigt bösartige Programme, die aus Quellen wie USB-Flash-Laufwerken oder dem lokalen Netzwerk ins System gelangen. Auch hier können alle relevanten Schutzmechanismen genutzt werden, und ein getestetes Programm wird durchlaufen, wenn es letztlich verhindert, dass der Computer infiziert wird. Auch hier werden alle Threats ausgeführt.

Der Performance Test untersucht, welche Auswirkungen jedes Programm auf die Geschwindigkeit der täglichen Computernutzung hat.

Ein mögliches Problem mit Antivirensoftware sind Fehlalarme, die harmlose, legitime Programme als Malware erkennen. Sowohl beim Real-World Protection Test als auch beim Malware Protection Test werden falsch-positive Tests durchgeführt, um sicherzustellen, dass die getesteten Programme den Benutzer nicht mit falschen Alarmen plagen. Bei Produkten mit einem hohen Grad an falsch positiven Ergebnissen wird der Award herabgestuft.

"Cyberkriminelle holen auf. Es ist wichtiger denn je, die Geräte zu schützen, egal ob es sich um einen Laptop, eine Workstation oder ein Smartphone handelt." – Peter Stelzhammer, co-founder, AV-Comparatives:

Zusätzlich wurden im ersten Halbjahr mehrere weitere Testberichte veröffentlicht, die verschiedene Sicherheitsaspekte abdecken, wie zum Beispiel einen VPN-Sicherheitstest, Router-Sicherheitstest, Stalkerware-Test, Mac-Sicherheitstest, Android-Sicherheitstest und Parental-Kontrolltest.

Peter Stelzhammer
AV-Comparatives
+43 720 115542
email us here


Source: EIN Presswire

AV-Comparatives releases results of 2020 Android Security Test

Android Mobile Security Award 2020 - AV-Comparatives

Android Mobile Security Award 2020 – AV-Comparatives

Logo AV-Comparatives

Logo AV-Comparatives

Mobile Security Test by AV-Comparatives

Mobile Security Test by AV-Comparatives

Mobile Security Products tested 2020 by AV-Comparatives

Mobile Security Products tested 2020 by AV-Comparatives

Mobile Security Test Results 2020 by AV-Comparatives

Mobile Security Test Results 2020 by AV-Comparatives

AV-Comparatives tested 9 popular security apps about malware protection, battery drain and anti-theft functionality.

Even as Google's built-in malware protection improved, it still offers the weakest protection of all tested products. We highly recommend using a third party app!”

— Peter Stelzhammer, co-founder, AV-Comparatives

INNSBRUCK, TYROL, AUSTRIA, July 7, 2020 /EINPresswire.com/ — Independent security testing lab AV-Comparatives has published the report of its 2020 investigation into antivirus apps for the Android mobile platform. The Innsbruck-based institute tested 9 popular security apps with regard to malware protection, battery drain and anti-theft functionality. Third-party products made by Avast, AVG, Avira, Bitdefender, G DATA, Kaspersky, Securion and Trend Micro were all scrutinised, along with Google’s built-in security measures in the Android platform.

The latest version of Google’s mobile OS, Android 10, was used for the test. Users who are planning on buying a new smartphone, or updating their existing phones to the newest OS version, can see how well the tested products perform on the latest incarnation of Android.

In the malware protection test, over 3,000 recent malicious applications for the Android operating system were used. The results clearly showed the advantage of using a third-party antivirus product to protect smartphones against Android malware.

To ensure that the tested products do not achieve protection at the expense of high rates of false alarms, a false-positives test was also run, using 500 popular legitimate apps.

Anti-theft functionality was also considered. This allows a user whose smartphone has been lost or stolen to e.g. locate it, lock it, and wipe private data. Anti-theft features in the tested products were tested for reliable operation.

A past criticism of security programs is that they cause significant drain on the device’s battery. AV-Comparatives addressed this issue by running a battery-drain test. The effect each product has on battery life during everyday phone usage (making calls, surfing the Internet, watching videos and sending emails) was measured.

As well as the results of the tests, the report includes general security advice and information for users of Android devices. The new security measures incorporated into Android 10 are considered, along with the effect these have on third-party security apps. Security tips for Android users are also provided.

Like all AV-Comparatives’ public reports, the report of the 2020 Android Mobile Security Test can be downloaded free of charge from the institute’s website, www.av-comparatives.org.

AV-Comparatives offers AVC UnDroid, a well done malware analysis tool, which is available free to all users. It is a static analysis system for detecting suspected Android malware and adware and providing statistics about it. Users can upload APK files and see the results in various analysis mechanisms.

Try it out: https://www.av-comparatives.org/specials/undroid/

Peter Stelzhammer
AV-Comparatives
+43 720 115542
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Awrel Unveils First Web-based Virtual Assistant Powering 24×7 Dental Emergency Screening, Triage and Question Answering

Awrel Emergency Dental Virtual Assistant

This turnkey chatbot from uses artificial intelligence to empower remote triage and management of dental emergencies

Dr. Alan Farber, Farber Center For Periodontics & Dental Implants

Dr. Alan Farber’s Long Island periodontics practice is among the first to use Awrel’s new Emergency Dental Virtual Assistant

Arnold Rosen, Founder and CEO of Awrel, dental software solutions innovator

Dr. Arnold Rosen and his colleagues at Awrel offer the first web-based chatbot to empower remote triage and management of dental emergencies

Amidst COVID-19's "new normal" distancing, AI-powered chatbot enables remote emergency management with streamlined communication and enhanced care processes

COVID requires dentists to reinvent themselves. Awrel provides a secure and cost-effective way to meet unprecedented demands for remote caregiving. It’s a win-win for practices and patients.”

— Alan Farber, DDS, International Association of Dental Specialists

BOSTON, MA, USA, July 7, 2020 /EINPresswire.com/ — To support COVID-19 demands and deliver an entirely new digital approach for emergency patient engagement, Awrel, a dental software solutions innovator, unveiled its new Emergency Dental Virtual Assistant. The turnkey chatbot, deployed by embedding a single snippet of code into an existing website, uses artificial intelligence (AI) to empower remote triage and management of dental emergencies.

This first-of-its-kind solution gives patients 24×7 access to screening and question-answering tools designed to collect relevant information and provide clinically vetted recommendations for next-step actions (self-care, appointment scheduling, etc.) Dental providers receive chatbot notifications via HIPAA-compliant text messaging. Follow-up patient communication is done via phone or Awrel’s HIPAA-compliant texting application. Data exchanged via the Awrel chatbot and texting applications can be readily transferred to the patient’s dental record.

“This is the way of the future, the new normal,” said Alan Farber, DDS. “Healthcare has seen major advances in digital patient engagement, yet HIPAA compliance has remained a challenge. Today, COVID requires dentists to reinvent themselves. Awrel’s solutions provide a secure and cost-effective way to meet unprecedented demands for remote caregiving. It’s a win-win for practices and patients.”

The bot is live at the site of Farber Center for Periodontics, https://longislandperio.com

While Dr. Farber initially deployed the chatbot to better meet existing customer needs, he and his colleagues were pleased to discover that it has generated several new patients. They have used Awrel’s virtual assistant since February to support their two New York-based practice locations.

According to Dr. Farber, 24×7 access to the screening tool allows patients to exchange information at a time and place that’s convenient to them. “Customer service is key in the new world of healthcare – and this approach is rock solid. Some patients are more willing to share information with a bot rather than with a live human, and to do so in a timelier fashion. Early intervention can enhance patient experience, improve treatment outcomes, and reduce treatment time.”

“From the start of this pandemic, we worked diligently to develop a solution that immediately supports dental providers seeking an efficient way to triage patients and answer questions while also addressing social distancing needs of staff and patients,” said Awrel Founder and CEO Arnold Rosen, DDS. “Awrel’s offerings are unlike others because they can easily be adapted to work seamlessly across the internet, mobile devices and smart speakers, and can readily integrate with existing tele-dental services.”

The Farber Center for Periodontics and Dental Implants is among the earliest adopters of Awrel’s chatbot. “The inherent value of virtual experiences is obvious,” Dr. Farber stated. “Patients and staff can better protect themselves against COVID. As an added benefit, our practice has saved valuable time and money by automating once-manual processes for emergency access and assessment.”

Dr. Farber learned about Awrel’s new chatbot during a webinar presented by the International Association of Dental Specialists, an organization he founded. Colleagues responded positively to this new technology, he stated. “Awrel’s tools are very well structured and have worked flawlessly for our practice. I see the use of chatbots as a benefit to any dentist.”

About Awrel
Boston-based Awrel, a dental software solution provider, delivers out-of-the-box and custom virtual assistants using conversational experiences and artificial intelligence to automate and document workflow, improve outcomes, reduce costs and enhance the patient and clinician experience. Awrel launched dentistry’s first HIPAA-compliant desktop and mobile texting application in 2016 and offers Awrel Voice™, a virtual assistant used on devices such as Amazon Echo or Google Home for hands-free lab ordering and other workflows. Each day, Awrel solutions facilitate thousands of data exchanges, including image, text and document sharing, individual and group messaging, collaborative transactions (ordering of custom prostheses, supplies and equipment, etc.) and cloud archiving. Dental solution providers enhance their offerings with Awrel via capabilities to define unique workflows, create product- and customer-specific applications, and private label the company’s solutions. https://awrel.com

Beth Strohbusch
Awrel
+1 414-213-8818
email us here


Source: EIN Presswire

Uproar regarding Shincheonji, Unfairly Blamed for COVID-19

Religious Leaders in North and South America Mobilize, Call for an End in the Mistreatment of Shincheonji Church in South Korea

DAEGU, SOUTH KOREA, July 7, 2020 /EINPresswire.com/ — Faith leaders from North and South America advocate for Shincheonji and its Chairman Man Hee Lee against false media portrayals and excessive government measures during the Coronavirus outbreak in South Korea in February.

In April, the United States Commission on International Religious Freedom (USCIRF) issued a statement “condemning” the stigmatization of Shincheonji during the pandemic.

The USCIRF cited the government’s excessive measures to exaggerate Shincheonji’s role in the outbreak, ranging from criminal charges, to a lockdown of the church and its activities.

“Governments around the world are undoubtedly busy responding to the public health crisis, but they still have an obligation to respect and protect religious freedom, especially for minority communities during and following this crisis,” USCIRF Vice Chair Gayle Manchin added.

To understand why Shincheonji was heavily stigmatized and targeted during South Korea’s outbreak, one must understand the country’s religio-political dynamic. Christian Protestantism is “predominant and mainstream, marginalizing moderate and liberal churches.” Their majority influence allows them to target groups such as Shincheonji church through politics and media.

“It is clear that religious and political leaders alike who are known opponents of Shincheonji are using their influence to blame an entire country’s pandemic on one organization” said Pastor Jerimiah Martin of The Well Church in United States.

He joins a committee of international Christian leaders who are advocating for Shincheonji.

“People who have worked with Shincheonji and personally come to know Chairman Lee will see beyond the rhetoric being used” said Martin.

One of these individuals is Juan Carlos Urquhart de Barros, Bishop of the Anglican Church of Uruguay. Urquhart de Barros is among many faith leaders working with Chairman Lee to bridge peace between religions. Through countless hours of talking and working together, he has seen Chairman Lee’s dedication to his faith.

“I am personally amazed by his ability to testify according to the Bible, on the standard of prophecy and fulfillment from beginning to end, without adding or subtracting. It is the best truth” said Urquhart de Barros. “Not only this, [Chairman Lee] lives every second according to it. Does a man in his late 80’s, who skips sleep and meals on world-travels in order to make time to discuss peace, really have much to gain personally? Does he not live in a sacrificial way to benefit others?”

In the United States, Ambassador of Sikh Dharma Bhai Sahib Satpal Singh Khalsa shared a similar perspective of Chairman Lee as he witnessed “the dedication and sacrifice he and his organizations commit themselves to for a better humanity.”

In fact, those who have worked alongside Chairman Lee have not only seen his sacrifice to make the world a better place but also the fruition of their peace efforts. Reverend Tuy Nguyen, the Vice President of Public Relations of the Cao Dai Temple in Texas attended peace summits in South Korea in 2014, 2016, 2018 and 2019. Through the span of five years, she saw a change in herself and her community.

“Since that day [in 2014], I started to believe in the possibility of peace and dedicated myself to become a Peace Messenger in every angle of my life. I started to create peace dialogues within my inner self, create a peace culture in my family, my community, my workplace and wherever I went whoever I spent time with.. [The volunteers] truly created a Peace Culture, and it points back to the work of one true Ambassador of Peace – Chairman Man Hee Lee.”

Recently, Chairman Lee encouraged the members of Shincheonji who recovered from COVID-19 to donate their plasma toward a vaccine, restating their commitment to protect the health and safety of their fellow citizens.

“I promised to cooperate for the benefit of humanity and the government’s policy and conferred with our church members so that the estimated 4,000 congregants who recovered from COVID-19 can provide their plasma to develop a good medicine to solve this infectious disease,” said Lee.”

As members volunteered to donate, Chairman Lee, who knew well their difficulties in recovery, thanked them for their effort.

“Our congregation members have received the blood of life of Jesus, the Son of God, and have been freed from sin. Like Jesus, through our blood (plasma) donation, I know that you have gathered your hearts in our collective wish to free all the people of the world from the pains of this disease,” Lee said.

“This is the work that needs to be done as citizens of this country and as true believers. It is keeping the command of Jesus of loving your neighbor as yourself, and I am thankful that you have gathered your hearts for this good work and in making this decision that is like the light. Let us all pray in the name of Jesus to exterminate COVID-19.”

Despite the donation, the city of Daegu is seeking 100 billion won ($82.3 million) for losses it claims is a consequence of the virus spreading through Shincheonji church. But international faith leaders say city officials are holding the church to an unfair standard and must immediately withdraw the lawsuit.

“The international community is watching. If the city files a lawsuit against Shincheonji, this means all over the world, every business or church or temple should have to pay fines for their members or workers getting sick. However, other countries are not doing that. Why is Korea prosecuting a religious organization for their members getting sick?” said Pastor Pedro Lopez of New Generation Church in United States.

“For those who have personally worked with Shincheonji and Chairman Lee as we have, Shincheonji is a bright light in South Korea that is shining and making a positive impact around the world. Leaders and citizens of South Korea, we ask of you to stand on the side of justice” said Martin.

Scott Alwin
Shincheonji
+1 562-344-5016
email us here


Source: EIN Presswire

Over 3,000 people in 73 countries have watched "The Dalai Lama — Scientist" for free

The Dalai Lama works with Steven Chu, Nobel Prize Winner in Physics.

Only six days left to view the film for free, until July 14th.

The Dalai Lama – Scientist offers viewers a chance to see the scientific side of the Dalai Lama, and conversations with great minds throughout the years.”

— Dr. Elizabeth Fernandez, Forbes Magazine

BARCELONA, SPAIN, July 7, 2020 /EINPresswire.com/ — The producers of "The Dalai Lama — Scientist" announced today that more than 3,000 people from 73 different countries around the world have joined the 85th birthday celebration of The Dalai Lama by viewing this award-winning film for free.

Here are the simple directions for watching the film:

1. Go to vimeo.com/ondemand/thedalailamascientist

2. Click on "rent" (do not click on buy) and DO NOT enter your credit card details

3. Once you click on rent, click on "Apply promo code" and enter FREE85TH or FREE85THBIRTHDAY then click "Apply"

4. Click on "Continue" and the film will be available for you to watch for 72 hours, for free.

The Director of this award-winning film, Dawn Gifford Engle, said, "We want to thank everyone who watched the film on the first day of this week-long celebration of The Dalai Lama and his immense contributions to the field of science." The Executive Producer of the film, Ivan Suvanjieff, added, "We are blown away at the response to the film so far and we encourage everyone to join the celebration."

The film is available to view for free for only six days more. The view for free offer ends on July 14th.

Dawn Engle
PeaceJam
+1 303-455-2099
email us here


Source: EIN Presswire

VetStem Biopharma Reaches New Stem Cell Treatment Milestone

Leading regenerative medicine company, VetStem Biopharma, has processed nearly 14,000 patient samples resulting in over 30,000 stem cell treatments.

POWAY, CALIFORNIA, USA, July 7, 2020 /EINPresswire.com/ — Leading regenerative veterinary medicine company, VetStem Biopharma, has reached a new stem cell treatment milestone. The San Diego based company has processed nearly 14,000 patient samples resulting in over 30,000 stem cell treatments for animals across the United States and Canada.

As the first company to provide adipose derived stem cell services to veterinarians in the United States and Canada, VetStem pioneered the use of adipose derived regenerative stem cells in veterinary medicine. VetStem Cell Therapy is primarily used for the treatment of orthopedic conditions such as osteoarthritis as well as torn tendons and ligaments in dogs, cats, and horses. In addition to domestic animals, VetStem has worked with multiple exotic animal organizations to provide stem cell therapy for several exotic species.

A number of veterinarians have also used VetStem Cell Therapy to treat alternative conditions under the company’s Clinical Research Programs. For instance, according to VetStem’s Director of Commercial Operations, Kristi Hauta, cats most commonly receive VetStem Cell Therapy for the treatment of diseases such as chronic kidney disease, gingivostomatitis, or inflammatory bowel disease. Mrs. Hauta stated, “Unfortunately cats are faced with several potentially life-threatening conditions with limited treatment options. One of our goals at VetStem is to compile high quality data to demonstrate the potential efficacy of stem cell therapy for some of these conditions.” While more data is needed, some preliminary results have been promising. Additional clinical research programs include canine back pain and canine keratoconjunctivitis sicca, more commonly known as ‘dry eye.’

With over 30,000 patient treatments and an average adverse event percentage of approximately 0.2%, VetStem endeavors to provide the highest quality stem cell processing services. VetStem has over 15 years of experiencing working within FDA Good Tissue Practices (GTP) guidelines and announced the formation of its human stem cell company, Personalized Stem Cells, Inc. (PSC), in 2018. PSC was formed to advance and legitimize stem cell therapy for humans by providing quality stem cell processing services within FDA approved clinical trials.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-led Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Kristi Hauta
VetStem Biopharma
+1 858-748-2004
email us here


Source: EIN Presswire

Colorado Restraint & Drug Death Should Be Investigated for Racism Link CCHR Says

Watchdog wants the use of “date rape” drug, ketamine, that can cause aggression and unconsciousness, banned in restraint use, following death of 23-year-old African American

Watchdog wants the use of “date rape” drug, ketamine, that can cause aggression and unconsciousness, banned in restraint use, following death of 23-year-old African American

Watchdog wants the use of “date rape” drug, ketamine, that can cause aggression and unconsciousness, banned in restraint use following death of African American

LOS ANGELES, CALIFORNIA, UNITED STATES, July 7, 2020 /EINPresswire.com/ — In a series of calls for government reforms to prevent institutional racism, the mental health industry watchdog Citizens Commission on Human Rights International (CCHR) called for a ban on enforced psychotropic drugging by paramedics or other medical personnel during police arrests. Rev. Fred Shaw, a spokesperson for CCHR, Executive Director of the NAACP Inglewood-South Bay branch, and former LAPD Deputy Sheriff, has written to the Colorado Governor Jared Polis and state attorney general Phil Weiser detailing concerns over the use of the controversial and powerful drug, ketamine, that was injected into African American, Elijah McClain, 23, during a police restraint in Aurora, Colorado in August 2019. Governor Polis recently issued an Executive Order reopening an investigation into the case.

During the restraint, Elijah struggled and cried, “I just can’t breathe correctly.” He had a heart attack on the way to the hospital and was declared brain dead.[1] Six days later, his family took him off life support and he died.[2] While a coroner could not determine the cause of death at the time, he noted that “an idiosyncratic drug reaction (unexpected reaction to a drug even at a therapeutic level) cannot be ruled out” in reference to the ketamine dosage.[3]

Ketamine is Food and Drug Administration-approved as an anesthetic agent for surgical procedures. Abused on the streets, it is known as a “date rape” drug because it causes disassociation; rape victims injected with it enter a state in which they feel as if their mind and body aren’t connected.[4] Because it also causes amnesia, you may not remember an assault the next day.[5]

While ketamine is used to sedate aggressive patients in emergency hospital room settings, this is prescribed off-label (not FDA approved).[6] Medical News Today reports that victims of ketamine “may lose consciousness or be confused and compliant.”[7]

In some cases, the drug has caused heart or breathing failure and required those injected to be revived or intubated. It was given to Elijah despite “the immediate effects on breathing and heart function that the drug induces.”[8]

Other health hazards and side effects of ketamine, even in low doses, include agitation and in higher doses, “violent behavior,” “severe anxiety, fear, panic, anxiety, exaggerated strength, and aggression, muscle rigidity, respiratory depression,” and more.[9]

Despite these aggression-causing adverse effects, according to an Aurora Fire Department press release, ketamine is “routinely utilized to reduce agitation” during arrests. One comment allegedly heard in the police body camera footage of Elijah’s restraint suggested the dose of ketamine given him may have been 500 milligrams. That approaches the dose of 700 milligrams that would produce up to 25 minutes of full surgical anesthesia for someone of McClain’s reported weight of 140 pounds.[10]

Elijah had not committed any crime when he was approached by police, nor was he armed. He was on the way home from a convenience store. The police had responded to a 911 caller who had reported a “suspicious person” in a ski mask—a mask his sister later said he wore because he “had anemia and would sometimes get cold.”

Rev. Shaw said, “The combination of the restraint and then being forcibly injected with a ‘date-rape’ psychotropic drug must have been terrifying for this young man. Such ‘medical’ drugs, given involuntarily in a street setting against a person’s will, should surely be investigated as a violation of a person’s constitutional rights and the practice stopped. It is cruel and unusual punishment that the Universal Declaration of Human Rights is supposed to protect us from.”

Neuroscientist Carl Hart, chair of Columbia University’s psychology department, was quoted by ABC News, stating: “Why anyone would be giving ketamine in that circumstance is beyond me. The major problem here is we should never be ordering any medication, and no one should be taking or given it against their will.”[11]

Rev. Shaw said institutional racism may have contributed to the arrest and also merits investigation. He said a eugenics mind-set has been created where African Americans are perceived as “violent” or “criminal.” As Duke Law Journal reported, “Over time, attitudes about eugenics, class, and disability combined to create the policies that led to our current nationwide system of punitive detention.”[12]

Yahoo! News exemplified this thinking, CCHR says, because while Elijah was crying for help, “many others who arrived later… chatted casually as McClain struggled for his final breaths.”[13] That Elijah’s pleas were dismissed as him “just messing around,” appears symptomatic of institutional racism, CCHR says. It has been embedded in the culture since eugenics started.

Rev. Shaw hopes that the effect of stereotyping African Americans will be addressed in any review of the circumstances that lead up to, during and following the death of Elijah, along with the use of a mind-altering drug on him or in any restraint.

CCHR is a mental health watchdog responsible for more than 180 laws that protect patients from damaging psychiatric practices. DONATE to support its work here: https://www.cchrint.org/cchrint-donate/

References:

[1] https://www.thecut.com/2020/06/the-killing-of-elijah-mcclain-everything-we-know.html

[2] https://theweek.com/articles/921867/glaring-question-about-police-killing-elijah-mcclain

[3] https://www.thecut.com/2020/06/the-killing-of-elijah-mcclain-everything-we-know.html

[4] https://www.medicalnewstoday.com/articles/320409.php; https://www.bloomberg.com/news/features/2019-02-05/ketamine-could-soon-be-used-to-treat-suicidal-ideation

[5] https://www.efficientgov.com/public-safety/articles/what-to-know-about-ketamine-a-common-date-rape-drug-8DxnS7OteEhx7UmX/

[6] https://www.lonestarinfusion.com/blog/ketamine-fda-approval

[7] https://www.medicalnewstoday.com/articles/320409.php

[8] “At urging of Minneapolis police, Hennepin EMS workers subdued dozens with a powerful sedative: EMS workers used date rape drug ketamine, stopping some suspects’ hearts or breathing,” The Star Tribune, 15 June 2018, https://www.startribune.com/at-urging-of-police-hennepin-emts-subdued-dozens-with-powerful-sedative/485607381/; https://www.nytimes.com/2018/06/16/us/ketamine-minneapolis-police.html

[9] https://www.drugs.com/illicit/ketamine.html

[10] “One glaring question about the police killing of Elijah McClain,” The Week, 26 June 2020,
https://theweek.com/articles/921867/glaring-question-about-police-killing-elijah-mcclain

[11] “Elijah McClain was injected with ketamine while handcuffed. Some medical experts worry about its use during police calls,” ABC News, 1 July 2020, https://www.nbcnews.com/news/us-news/elijah-mcclain-was-injected-ketamine-while-handcuffed-some-medical-experts-n1232697

[12] Laura Iappleman, “Deviancy, Dependency, and Disability: The Forgotten History of Eugenics and Mass Incarceration,” Duke Law Journal, Vol. 68, No. 3, Dec. 2018, https://scholarship.law.duke.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=3958&context=dlj

[13] “‘I’m just different’: The family of Elijah McClain, a 23-year-old Black man killed by Colorado cops almost a year ago, is still waiting for justice,” Yahoo! News, 27 June 2020, https://news.yahoo.com/im-just-different-the-family-of-elijah-mc-clain-a-23-yearold-black-man-killed-by-colorado-cops-090048258.html

Amber Rauscher
Citizens Commission on Human Rights
+1 323-467-4242
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Global Organic Infant Formula Milk Powder Market Analysis 2020 – Dynamics, Trends, Revenue, Outlook & Forecast Till 2026

Latest Market Analysis Research Report on “Global Organic Infant Formula Milk Powder Market” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, July 7, 2020 /EINPresswire.com/ — Global Organic Infant Formula Milk Powder Industry

New Study Reports “Organic Infant Formula Milk Powder Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Market Overview

The report of the Global Organic Infant Formula Milk Powder Market provides in-depth segment analysis with valuable insights at the macro as well as micro levels. Analysis of significant segments which offer considerable opportunities or account for significant share has also been included in the analysis of the Global Organic Infant Formula Milk Powder Market. This research study is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. The reports are single-point solutions for businesses to grow, evolve, and mature. The report further maps on market segments and geographies. The base year for the market is calculated to be from 2020 to 2026.

Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients. Organic farming is a method of production that is concerned with respecting natural balances. It is committed to sustainable management, respecting natural balances and biodiversity, and producing high quality products in a way that is not harmful to the environment or health. 

In 2016, the global organic infant formula market is led by Europe, capturing about 56.03% of global organic infant formula consumption. USA is the second-largest region-wise market with 17.77% global consumption share.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Organic Infant Formula Milk Powder 3900 market in 2020.

Try Free Sample of Global Organic Infant Formula Milk Powder Market @   https://www.wiseguyreports.com/sample-request/5233149-global-organic-infant-formula-milk-powder-market-insights-forecast-to-2026

The following manufacturers are covered in this report:
Holle
Bellamy
Topfer
Supermum
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Angisland
Yeeper
Shengyuan
Shengmu
Mengniu

Organic Infant Formula Milk Powder Breakdown Data by Type
Wet Process Type
Dry Process Type
Other

Regional Description

The request for regional description is explained in this section with the perfect combination of the right sense of fact-oriented problem-solving methodologies and leveraging existing data repositories. The market initiative and new development are observed in the regions of Europe, Middle East & Africa, Asia Pacific, Latin America, and North America. These regions are studied regarding the established trends and mounting opportunities that could benefit the Global Organic Infant Formula Milk Powder Market in the future timeframe.

Organic Infant Formula Milk Powder Breakdown Data by Application
First Stage
Second Stage
Third Stage

Report covers:

Comprehensive research methodology of Global Organic Infant Formula Milk Powder Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Organic Infant Formula Milk Powder Market.
Insights about market determinants which are stimulating the Global Organic Infant Formula Milk Powder Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5233149-global-organic-infant-formula-milk-powder-market-insights-forecast-to-2026

Some points from table of content:

1 Study Coverage
2 Executive Summary
3 Global Organic Infant Formula Milk Powder Competitor Landscape by Players
4 Breakdown Data by Type (2015-2026)
5 Breakdown Data by Application (2015-2026)
6 North America
7 Europe
8 Asia Pacific
9 Latin America
10 Middle East and Africa
11 Company Profiles
11.1 Holle
11.1.1 Holle Corporation Information
11.1.2 Holle Description, Business Overview and Total Revenue
11.1.3 Holle Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Holle Organic Infant Formula Milk Powder Products Offered
11.1.5 Holle Recent Development
11.2 Bellamy
11.3 Topfer
11.4 Supermum
11.5 The Hain Celestial Group
11.6 Nature One
11.7 Perrigo
11.8 Babybio
11.9 Gittis
11.10 Humana
11.1 Holle
11.12 Ausnutria
11.13 Nutribio
11.14 HealthyTimes
11.15 Arla
11.16 Angisland
11.17 Yeeper
11.18 Shengyuan
11.19 Shengmu
11.20 Mengniu
12 Future Forecast by Regions (Countries) (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
16 Appendix

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire